WHO Drug Information (original) (raw)
WHO drug information provides an overview of topics of current relevance relating to drug development and regulation. Latest lists of proposed and recommended International Nonproprietary Names for Pharmaceutical Substances (INN) are also included.
About WHO Drug Information
WHO Drug Information is a quarterly journal providing an overview of topics relating to medicines development and regulation which is targeted to a wide audience of health professionals and policy makers.
Launched in 1987, WHO Drug Information communicates the latest international news and trends to regulatory agencies, academic and training institutions, researchers, consumer bodies, and pharmaceutical manufacturers and focuses on topics impacting the safety, efficacy and quality of medicines, medical products, herbals and biomedicines. It presents a range of perspectives on how current challenges impact the manufacture, prescribing and access of medicines throughout the world and introduces newly-released guidance documents.
For enquiries, please send an e-mail to druginfo@who.int
Information developed by WHO:
Guidelines and recommendations concerning medicines, biologicals, vaccines, medical devices, herbals and related products
Subscription
Subscription information:
WHO Drug Information provides an overview of topics relating to drug development and regulation that are of current relevance and importance, and includes the lists of proposed and recommended International Nonproprietary Names for Pharmaceutical Substances (INN).
WHO Drug Information is published 4 times a year.
To subscribe, please send an e-mail to druginfo@who.int
or order from
Latest issue
The third issue of volume 38 includes: Consultation Document: "Good practices of national regulatory authorities in implementing the collaborative registration procedures for medical products" The International Nonproprietary Names (INN) Recommended...
Revisions of the Essential Medicines lists
International Nonproprietary Names (INN)
Information from research institutions, medical journals and regulatory authorities:
- Commentaries on clinical trials of drugs important for regulatory authorities
- Newly reported adverse reactions
- Dangerous drug combinations
- Drug warnings and amendments to product information
- Changes in treatment
- News briefs
- Articles on issues of current concern
Published issues
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
- Volume 20, index pdf, 21kb
- Volume 20, number 4
- Volume 20, number 3
- Volume 20, number 2
- Volume 20, number 1